Christina Brock

Dr. Christina Brock


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in Pharmacological Reviews
Verified
Journal Article
Closed access
PDF file
JOJessica O'NEill
Jessica O'NEill
CBChristina Brock
Christina Brock
AOAnne Estrup Olesen
Anne Estrup Olesen
TATrine Andresen
Trine Andresen
MNMatias Nilsson
Matias Nilsson
ADAnthony H. Dickenson
Anthony H. Dickenson
A large number of pharmacological studies have used capsaicin as a tool to activate many physiological systems, with an emphasis on pain research but also including functions such as the cardiovascular system, the respiratory system, and the urinary tract. Understanding the actions of capsaicin led to the discovery its receptor, transient receptor potential (TRP) vanilloid subfamily member 1 (TRPV1), part of the superfamily of TRP receptors, sensing external events. This receptor is found on key fine sensory afferents, and so the use of capsaicin to selectively activate pain afferents has been exploited in animal studies, human psychophysics, and imaging studies. Its effects depend on the dose and route of administration and may include sensitization, desensitization, withdrawal of afferent nerve terminals, or even overt death of afferent fibers. The ability of capsaicin to generate central hypersensitivity has been valuable in understanding the consequences and mechanisms behind enhanced central processing of pain. In addition, capsaicin has been used as a therapeutic agent when applied topically, and antagonists of the TRPV1 receptor have been developed. Overall, the numerous uses for capsaicin are clear; hence, the rationale of this review is to bring together and discuss the different types of studies that exploit these actions to shed light upon capsaicin working both as a tool to understand pain but also as a treatment for chronic pain. This review will discuss the various actions of capsaicin and how it lends itself to these different purposes.

1 October 2012 in Drugs
Verified
Journal Article
Closed access
PDF file
CBChristina Brock
Christina Brock
SOSøren Schou Olesen
Søren Schou Olesen
AOAnne Estrup Olesen
Anne Estrup Olesen
JFJens Brøndum Frøkjaer
Jens Brøndum Frøkjaer
TATrine Andresen
Trine Andresen
ADAsbjørn M. Drewes
Asbjørn M. Drewes

4 January 2016 in Neurogastroenterology & Motility
Verified
Journal Article
Open access
PDF file
JFJens Brøndum Frøkjær
Jens Brøndum Frøkjær
SBS. Bergmann
S. Bergmann
CBChristina Brock
Christina Brock
AMA. Madzak
A. Madzak
AFA. D. Farmer
A. D. Farmer
ADAsbjørn M. Drewes
Asbjørn M. Drewes
Background: The parasympathetic nervous system, whose main neural substrate is the vagus nerve, exerts a fundamental antinociceptive role and influences gastrointestinal sensori‐motor function. Our research question was to whether combined electrical and physiological modulation of vagal tone, using transcutaneous electrical vagal nerve stimulation (t‐VNS) and deep slow breathing (DSB) respectively, could increase musculoskeletal pain thresholds and enhance gastroduodenal motility in healthy subjects.Methods: Eighteen healthy subjects were randomized to a subject‐blinded, sham‐controlled, cross‐over study with an active protocol including stimulation of auricular branch of the vagus nerve, and breathing at full inspiratory capacity and forced full expiration. Recording of cardiac derived parameters including cardiac vagal tone, moderate pain thresholds to muscle, and bone pressure algometry, conditioned pain modulation using a cold pressor test and a liquid meal ultrasonographic gastroduodenal motility test were performed.Key Results: Cardiac vagal tone increased during active treatment with t‐VNS and DSB compared to sham (p = 0.009). In comparison to sham, thresholds to bone pain increased (p = 0.001), frequency of antral contractions increased (p = 0.004) and gastroduodenal motility index increased (p = 0.016) with active treatment. However, no effect on muscle pain thresholds and conditioned pain modulation was seen.Conclusions & Inferences: This experimental study suggests that this noninvasive approach with combined electrical and physiological modulation of vagal tone enhances gastroduodenal motility and reduces somatic pain sensitivity. These findings warrant further investigation in patients with disorders characterized with chronic pain and gastrointestinal dysmotility such as functional dyspepsia and irritable bowel syndrome.

1 August 2010 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
SOSøren Schou Olesen
Søren Schou Olesen
CBChristina Brock
Christina Brock
AKAnne Lund Krarup
Anne Lund Krarup
PFPeter Funch–Jensen
Peter Funch–Jensen
LALars Arendt-Nielsen
Lars Arendt-Nielsen
ADAsbjørn Mohr Drewes
Asbjørn Mohr Drewes

12 December 2016 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
PDF file
CBChristina Brock
Christina Brock
BBB. Brock
B. Brock
QAQasim Aziz
Qasim Aziz
HMHolger Jon Møller
Holger Jon Møller
MJM. Pfeiffer Jensen
M. Pfeiffer Jensen
AFA. D. Farmer
A. D. Farmer

14 December 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
TOTina Okdahl
Tina Okdahl
AWAnne-Marie Wegeberg
Anne-Marie Wegeberg
FPFlemming Pociot
Flemming Pociot
BBBirgitte Brock
Birgitte Brock
JSJoachim Størling
Joachim Størling
CBChristina Brock
Christina Brock
Objectives To investigate low-grade inflammation in type 2 diabetes and explore associations to clinical aspects as well as microvascular and macrovascular complications. Design Cross-sectional analysis. Setting The outpatient diabetes clinic at the Department of Endocrinology at Aalborg University Hospital, Denmark. Participants 100 participants with type 2 diabetes confirmed by a haemoglobin A1c (HbA1c)≥6.5% for a minimum of 1 year and 21 healthy controls. Outcome measures Serum levels of 27 inflammation-related biomarkers measured by immunoassay. Associations with microvascular and macrovascular complications, body weight, glycaemic control, medication and sex were investigated in the diabetes cohort. Results Serum levels of tumour necrosis factor (TNF)-α and eotaxin were elevated in type 2 diabetes (p<0.05), while interleukin (IL)-7 was decreased (p<0.001). IL-12/IL-23p40, IL-15, macrophage-derived chemokine (MDC) and C reactive protein (CRP) levels were increased with body weight (p<0.05), while eotaxin and TNF-α were increased with elevated HbA1c levels (p<0.04). Dipeptidyl peptidase-4 inhibitor therapy was associated with lower levels of induced protein-10, MDC and thymus and activation regulated chemokine (p<0.02), while females had higher levels of MDC (p=0.027). Individuals with ≥3 diabetic complications had elevated levels of IL-6, IL-10, IL-12/IL-23p40, IL-15 and CRP compared with those with ≤3 (p<0.05). Conclusion The level of low-grade inflammation in type 2 diabetes is associated with obesity, glycaemic regulation, therapeutical management, sex and complications. Our results underline the importance of addressing inflammatory issues in type 2 diabetes, as these may predispose for crippling comorbidities.